CCHT Medication Administration and Anticoagulation 2

Question 1

A hemodialysis patient receives intravenous sodium bicarbonate during treatment. What is the primary indication for this medication?

Accepted Answer

Metabolic acidosis

Answer

Hypernatremia

Answer

Hypercalcemia

Answer

Hyperphosphatemia

Question 2

Which phosphate binder is commonly administered with meals to dialysis patients to control serum phosphorus levels?

Accepted Answer

Calcium carbonate or sevelamer

Answer

Aluminum hydroxide only

Answer

Sodium polystyrene sulfonate

Answer

Cholestyramine

Question 3

When using a continuous heparin infusion during dialysis, what laboratory test is used to monitor anticoagulation levels?

Accepted Answer

Activated clotting time (ACT) or APTT

Answer

Prothrombin time (PT)

Answer

Platelet count

Answer

Serum creatinine

Question 4

A patient on hemodialysis develops heparin-induced thrombocytopenia (HIT). Which finding on laboratory results would support this diagnosis?

Accepted Answer

Platelet count drop of >50% from baseline

Answer

Elevated hemoglobin

Answer

Increased white blood cell count

Answer

Elevated serum potassium

Question 5

What is the purpose of administering vitamin D analogs (e.g., calcitriol) to hemodialysis patients?

Accepted Answer

Suppress secondary hyperparathyroidism and manage bone disease

Answer

Treat metabolic acidosis

Answer

Lower blood pressure

Answer

Reduce fluid overload

Question 6

Which route of administration is preferred for erythropoiesis-stimulating agents (ESAs) in hemodialysis patients?

Accepted Answer

Intravenous or subcutaneous

Answer

Oral

Answer

Intramuscular

Answer

Transdermal

Question 7

A dialysis patient's hemoglobin rises above 13 g/dL while on ESA therapy. What is the appropriate action?

Accepted Answer

Reduce or hold the ESA dose

Answer

Increase the ESA dose

Answer

Discontinue ESA and monitor

Answer

Add an oral iron supplement